U.S. Sees Hazardous APIs In Supplements Sourced From China, Asia
This article was originally published in PharmAsia News
Executive Summary
China continues to export, at least to the United States, previously identified hazardous drugs, some carcinogens, as ingredients in supplements for all kinds of uses